BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

MMS Holdings, Inc. Hosts 2011 Scientific Symposium


9/22/2011 10:16:48 AM

Canton, MI (September 21, 2011) - MMS Holdings Inc. is pleased to share news of a successful 2011 Scientific Symposium. This meeting of industry professionals and researchers was held on Wednesday, August 10th, 2011 at the MMS global headquarters in Canton, Michigan. This near capacity event was open to all colleagues in the pharmaceutical and biotech arenas. After a brief note of welcome, Stuart Dombey, M.B., F.R.C.P., Chief Scientific and Regulatory Officer and Founder at QuatRx Pharmaceuticals, shared an insightful presentation on the "Patterns in the Regulatory Environment" followed by a presentation from Mark P. Fletcher, MD FAAAAI, Clinical Board Member titled "Biosimilars Development: The Regulatory Challenges". The final presentation and discussion was led by R. Michael Poole, MD, Chief Medical Officer at Link Medicine Corporation on the topic of "Autophagy and the Mitochondrial Life-Cycle."

"We were pleased to host the symposium event again this year. The industry we work in is ever-changing and we value the opportunity to meet as a scientific and technical team to discuss novel therapy and topics that most influence the environment we work in" said Kelly J. Hill, Director of Project and Account Management at MMS Holdings. "It was a great honor to have these pharma industry leaders join us for this discussion."

We hope you join us next year for this great scientific gathering.

To view our 2011 Scientific Symposium agenda click here.

To view photos from the event visit our Facebook page here.

About MMS Holdings Inc.

MMS Holdings Inc. is based in Canton, MI and is a highly experienced pharmaceutical service organization that is focused on quality deliverables in the areas of Clinical Programming, Biostatistics, Medical /Regulatory Writing and Comprehensive Pharmacovigilance. Commitment to Quality deliverables with robust submission experience sets MMS apart from traditional service providers. MMS Holdings Inc. is ISO-9001 certified for all services and maintains detailed quality metrics for every project. For more information visit: http://www.mmsholdings.com


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->